Moderna will supply up to 500 million doses of the COVID-19 vaccine to COVAX, a United Nations-funded program supporting people in low and middle-income countries by the end of 2022, the announcement said. It comes days after the World Health Organization (WHO) added a two-dose prod to the list for emergency use, marking a fifth vaccine to receive that approval.
“I am grateful to our partners Gavi and COVAX for their tireless work and to the entire Moderna team for working together to achieve this deal,” Moderna CEO Stephane Bancel said in a statement posted on the company’s website. On Monday, “This is a milestone as we take steps to ensure that people around the world have access to our COVID-19 vaccine. We recognize that many countries have limited resources to access the COVID-19 vaccine. COVAX’s mission is to ensure affordable, broad-spectrum vaccines and Equal access to the COVID-19 vaccine and we remain committed to doing everything we can to end this ongoing outbreak with our mRNA COVID-19 vaccine.
Last week, Moderna announced an investment initiative to expand global production capacity to 3 billion doses by 2022 and raise its 2021 production supply forecast to between 800 million and 1 billion doses.
Why is India’s Corona Virus data countless?
The first vaccine allocation is expected to be delivered later this year. But most of the 466 million will be sent in 2022. In addition, the COVAX project is backed by Sweden, which announced it will donate 1 AstraZeneca million images.
“Sweden’s announcement that it will share 1 million doses of the COVID-19 vaccine with COVAX is a great gesture that must be repeated urgently and over and over again by governments around the world to accelerate the fair rollout of the vaccine across the world.” The world, “WHO director-general Dr. Tedros Adhanom Ghebreyesus said in a statement on Monday. “The support will ensure that people in vulnerable countries, especially Africa, will be able to get their second intake through the COVAX initiative, Sweden’s most generous support is timely when. Occurring at the time when the world needs it most. “
The program has come under fire from supply issues in recent weeks, when India, a major producer of AstraZeneca jab, banned exports as it turned its attention to the home crisis, Tedros said the project. The 20 million “urgent” doses are expected in the second quarter of 2021. It is unclear when India will return to shipments as it faces a shortage of supply and demand for vaccines among the population. Own The United States has pledged to send raw materials to India to help make vaccines, oxygen, personal protective equipment and other equipment needed to fight the catastrophic tidal wave.
Click here for complete corona Virus protection.
“We are delighted to sign this new agreement with Moderna, giving COVAX Facility participants access to another highly effective vaccine,” Gavi CEO Dr. Seth Berkley said in a press release. “Expanding and diversifying a portfolio has always been a primary focus of COVAX, and it remains adaptive in the face of this evolving outbreak, as well as the growing threat of the pattern. This deal is another step in that direction. “